Founded

Address

Venrock Associates
55 Cambridge Parkway
Suite 100
Cambridge, MA 02142
United States

Open map

Venrock Associates
Palo Alto, CA 00000
United States

Open map


Recent investment activity

KANDO id: 32106

Corporate information

Registration country

Company type

The venture capital arm of the Rockefeller Family.

Funding rounds

Investment preferences

Minimum investment (USD)
2,000,000
Maximum initial investment (USD)
40,000,000
Investment size comment
USD 10 million sweet spot.
Stage focus
Investment focus themes
Actual initial investment stage
N/A (147)
Series A (19)
Venture (2)

Investment activity status
Active investor

Selected investments

Displaying 76 - 100 of 283
Profile Country Date Funding
Caliper Life Sciences Inc N/A Initial investment
Canesta Inc Provider of electronic perception technology in the United States. Series E
Canesta Inc Provider of electronic perception technology in the United States. N/A
Canesta Inc Provider of electronic perception technology in the United States. N/A
CardioThoracic Systems Inc N/A Initial investment
Castle Networks Inc N/A Initial investment
Castlight Health Inc Series D
Castlight Health Inc Series C
Celladon Corp N/A Initial investment
Centocor Inc N/A Initial investment
Cerulean Pharma Inc Series D Initial investment
Cerulean Pharma Inc Series C Initial investment
Cerulean Pharma Inc Series B Follow-on investment
Cerulean Pharma Inc Series A Initial investment
Check Point Software Technologies Ltd Communications software company for intra- and inter-networking security. N/A Initial investment
Ciclon Semiconductor Device Corp High-frequency, high-efficiency RF LDMOS and power MOSFET semiconductor company. Series A Initial investment
Cloudflare Inc Web performance and security company. Series B
Cloudflare Inc Web performance and security company. Series A
CodeRyte Inc Natural Language Processing for computer-assisted coding of medical dictation notes for medical billing. N/A Initial investment
Cognex Corp N/A Initial investment
Coley Pharmaceutical Group Inc N/A Initial investment
Constellation Pharmaceuticals Inc Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics Series B Follow-on investment
Constellation Pharmaceuticals Inc Rapidly Advancing Emerging Epigenetics Research to Develop Novel Oncology Therapeutics Series A Initial investment
Coretrace Corp Develops security software for enterprise computing platforms based on next generation "white listing" application control technology Series A Initial investment
Crescent Networks Mobile & Telecommunications/Telecom Devices & Equipment company N/A Initial investment

Current team

Past employees

Selected Products / Customers

Financials